DP

DRUG4 trials

Sponsors

Samsung Medical Center, Medecins Sans Frontieres, Netherlands, Philipps University Marburg, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Conditions

Gastric CancerMetabolic SyndromeMetastasesPainUncomplicated Falciparum Malaria

Phase 3

Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer

CompletedNCT00313872

Samsung Medical CenterGastric Cancer, Metastases

Start: 2003-05-31End: 2010-01-31Updated: 2012-01-12

Phase 4

Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria

Medecins Sans Frontieres, NetherlandsUncomplicated Falciparum Malaria

Start: 2008-12-31End: 2009-12-31Target: 600Updated: 2009-05-15

Unknown Phase

Investigating Hope and Expectations in Open-Label Placebos

CompletedNCT03517644

Philipps University MarburgPain

Start: 2018-02-10End: 2018-08-21Updated: 2018-08-23

Effect of Functional Foods on Gut Microbiota in Metabolic Syndrome

CompletedNCT03611140

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranMetabolic Syndrome

Start: 2014-01-10End: 2018-07-15Updated: 2018-08-02

Related Papers

Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome

Journal of the American Heart Association2019-08-27146 citations

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.

2010-09-09151 citations